GHIMENTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 6.595
EU - Europa 3.691
AS - Asia 3.657
SA - Sud America 569
AF - Africa 191
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.731
Nazione #
US - Stati Uniti d'America 6.408
IT - Italia 1.412
SG - Singapore 1.082
CN - Cina 1.047
HK - Hong Kong 494
DE - Germania 477
SE - Svezia 462
BR - Brasile 454
VN - Vietnam 323
BG - Bulgaria 225
FR - Francia 207
FI - Finlandia 197
GB - Regno Unito 191
CA - Canada 141
TR - Turchia 140
IN - India 133
RU - Federazione Russa 110
JP - Giappone 108
AT - Austria 101
KR - Corea 83
CI - Costa d'Avorio 71
UA - Ucraina 51
NL - Olanda 45
BD - Bangladesh 39
PL - Polonia 34
AR - Argentina 28
ES - Italia 27
CH - Svizzera 25
IQ - Iraq 25
BE - Belgio 23
SN - Senegal 23
IR - Iran 22
ZA - Sudafrica 21
AU - Australia 19
ID - Indonesia 19
MA - Marocco 19
UZ - Uzbekistan 19
GR - Grecia 17
IE - Irlanda 17
MX - Messico 17
PK - Pakistan 17
EC - Ecuador 16
CO - Colombia 15
VE - Venezuela 15
UY - Uruguay 13
TW - Taiwan 12
CZ - Repubblica Ceca 11
MY - Malesia 11
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
KE - Kenya 10
NG - Nigeria 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
EG - Egitto 8
HU - Ungheria 8
JO - Giordania 8
IL - Israele 7
JM - Giamaica 7
PE - Perù 7
PY - Paraguay 7
LB - Libano 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
DK - Danimarca 5
LT - Lituania 5
AZ - Azerbaigian 4
BY - Bielorussia 4
EE - Estonia 4
ET - Etiopia 4
HN - Honduras 4
NP - Nepal 4
QA - Qatar 4
AO - Angola 3
BO - Bolivia 3
CR - Costa Rica 3
GE - Georgia 3
GT - Guatemala 3
PA - Panama 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BB - Barbados 2
BJ - Benin 2
GA - Gabon 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AM - Armenia 1
CD - Congo 1
Totale 14.710
Città #
Ashburn 764
Singapore 610
San Jose 493
Dallas 483
Hong Kong 481
Chandler 419
Woodbridge 366
Santa Clara 361
Fairfield 347
Serra 335
Ann Arbor 286
Beijing 244
Milan 212
Shanghai 210
Sofia 197
Houston 184
New York 180
Los Angeles 143
Seattle 134
Wilmington 134
Princeton 115
Boardman 110
Cambridge 110
Council Bluffs 99
Tokyo 95
Munich 93
Frankfurt am Main 88
Helsinki 87
Florence 84
Hefei 83
Lawrence 82
Pisa 80
Lauterbourg 77
Ottawa 75
Seoul 74
Abidjan 71
Livorno 69
Ho Chi Minh City 68
Medford 68
Hanoi 67
Vienna 67
Izmir 66
Rome 53
Ogden 50
Bremen 49
Redwood City 48
Des Moines 46
Nanjing 46
Jacksonville 43
Buffalo 41
Dong Ket 40
Lancaster 37
Turku 37
Istanbul 34
São Paulo 34
Orem 31
Redondo Beach 30
Marseille 27
Nanchang 27
London 26
San Diego 26
Atlanta 25
Pune 25
Paris 24
Nuremberg 23
Warsaw 23
Dakar 22
Boulder 21
Chennai 21
Dearborn 21
Lappeenranta 21
Amsterdam 20
Plovdiv 20
Brussels 19
Chicago 19
Hyderabad 19
Brooklyn 17
Norwalk 16
San Francisco 16
Lucca 15
Rio de Janeiro 15
Tashkent 15
Toronto 15
Vancouver 15
Bern 14
Da Nang 13
Dublin 13
Haiphong 13
Kunming 13
Montreal 13
Boston 12
Jiaxing 12
Nürnberg 12
Washington 12
Fuzhou 11
Palermo 11
Auburn Hills 10
Changsha 10
Düsseldorf 10
Montevideo 10
Totale 9.772
Nome #
A breath sampling system assessing the influence of respiratory rate on exhaled breath composition 297
Breath Analysis: Analytical Methodologies and Clinical Applications 295
A snow/firn four-century record of polycyclic aromatic hydrocarbons (PAHs) and polychlorobiphenyls (PCBs) at Talos Dome (Antarctica). 282
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 273
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation 265
Release of harmful volatile organic compounds (VOCs) from photo-degraded plastic debris: A neglected source of environmental pollution 251
Determination of salivary alpha-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test 242
Potentiometric sensor for non invasive lactate determination in human sweat 239
A dual mode breath sampler for the collection of the end-tidal and dead space fractions 237
Comparison of sampling bags for the analysis of volatile organic compounds in breath 227
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure 225
The effect of sampling procedures on the urate and lactate concentration in oral fluid 222
A four century firn record of PAHs and PCBs at Talos Dome, Victoria Land (Antartica) 220
The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis 216
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 215
Multi-Analytical Approach to Characterize the Degradation of Different Types of Microplastics: Identification and Quantification of Released Organic Compounds 208
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 208
Spatial and temporal trends of organic pollutants in Antarctica 204
Uric acid is the major determinant of absorbance in spent dialysate allowing spectrophotometric evaluation of dialysis dose 204
Micro-extraction by packed sorbent combined with UHPLC-ESI-MS/MS for the determination of prostanoids and isoprostanoids in dried blood spots 195
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
Effects of long-term vegan diet on breath composition 194
Determination of biomarkers in oral fluid for monitoring heart failure patients 193
Determination of volatile organic compounds in human breath for monitoring heart failure patients 188
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 187
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 185
Monitoring breath during oral glucose tolerance tests 182
Saliva sampling: Methods and devices. An overview 181
Determination of sevoflurane and isopropyl alcohol in exhaled breath by thermal desorption gas chromatography-mass spectrometry for exposure assessment of hospital staff 179
Monitoraggio non invasivo di terapie anticoagulanti orali 178
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 175
Analysis of isoprostanes in oral fluid using micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry to monitor oxidative stress in healthy adults performing physical activity 175
Predicting Heart Failure Patient Events by Exploiting Saliva and Breath Biomarkers Information 172
Saliva as a non-invasive tool for monitoring oxidative stress in swimmers athletes performing a VO2max cycle ergometer test 172
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 171
Sampling bags for breath analysis 168
Estimation of Heart Failure Patients Medication Adherence through the Utilization of Saliva and Breath Biomarkers and Data Mining Techniques 166
A computational approach for the estimation of heart failure patients status using saliva biomarkers 165
Caratterizzazione chimica dell'espirato umano in pazienti affetti da diabete mediante GC/MS 164
DETERMINATION OF BIOMARKERS IN BREATH AND SALIVA FOR MONITORING HEART FAILURE PATIENTS 162
Aspetti metodologici del campionamento dell’espirato 161
Pervasive sensors for real time monitoring 160
Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy 158
Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath:pharmacokinetic models for assessing liver function 158
Type-specific inflammatory responses of vascular cells activated by interaction with virgin and aged microplastics 158
Diet and other factors affecting the variability of breath composition 155
A low-cost internal standard loader for solid-phase sorbing tools 150
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 150
A purge and trap method for the analysis of volatile organic compounds in human oral fluid 147
Spectrophotometric measurement of uric acid in spent dialysate for estimating dialysis dose 145
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 145
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 141
Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma 139
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 138
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 137
May oral fluid analysis complement INR assay in the prevention of adverse events? 134
Saliva tests: application to drug and health care monitoring 133
Biological studies with comprehensive 2D-GC-HRMS screening: Exploring the human sweat volatilome 131
Methodological aspects of dried blood spot sampling for the determination of isoprostanoids and prostanoids 131
Micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry for the analysis of prostanoids and isoprostanoids in dried blood spots of preterm newborns suffering from patent ductus arteriosus 130
Effect of sampling procedures for the chemical characterization of oral fluid in clinical applications 129
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol 128
Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease 125
Monitoring of warfarin therapy by saliva analysis: an open issue on the way to clinical practice 124
NEEDLE TRAP MICRO-EXTRACTION: A NEW STRATEGY FOR THE COLLECTION AND PRECONCENTRATION OF BREATH SAMPLES 123
Stability of volatile organic compounds in sorbent tubes following SARS-CoV-2 inactivation procedures 122
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 121
THE EFFECT OF EXERCISE ON SALIVARY LACTATE, ALPHA-AMYLASE AND URIC ACID IN HEALTHY VOLUNTEERS 119
Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS) 119
Salivary lactate and 8-isoprostaglandin F2α as potential non-invasive biomarkers for monitoring heart failure: a pilot study 118
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 118
Development of an Analytical Procedure for the Quantification of Volatile Compounds in Human Breath 117
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 115
A breath sampler prototype to collect end-tidal and dead space fractions 115
Influence of sampling on the measured concentration of warfarin and warfarin alcohols in oral fluid 114
Spectrophotometric and spectrofluorimetric analysis of spent dialysate should allow monitoring of dialysis adequacy even if urea concentrations cannot be determined by these methods 113
Determination of peppermint compounds in breath by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 113
Determination of warfarin and warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 111
Correlation between warfarin salivary concentration and anticoagulant effect 108
Determination of bound and unbound warfarin and its metabolites in human plasma 105
Sport in town: The smart healthy env project, a pilot study of physical activity with multiparametric monitoring 105
Volatile Compounds in Human Breath During Oral Glucose Tolerance Test 104
Advances in breath and saliva analysis 104
Correlazione tra contenuto salivare di farmaci anticoagulanti in pazienti trombotici ed effetto anticoagulante 101
Pharmacokinetic models of post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite as measured in exhaled breath 101
Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications 100
Determination of volatile organic compounds in human breath samples for heart failure monitoring 97
Determinazione del warfarin in campioni di saliva e plasma raccolti da pazienti in terapia anticoagulante 94
A sampler prototype for the simultaneous collection of exhaled air and breath condensate 91
null 89
A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners 87
The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients 86
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 83
null 69
Determination of volatile organic compounds in human breath samples for heart failure monitoring 65
Dried blood spot analysis of long-chain polyunsaturated fatty acids and oxylipins for monitoring heart failure 47
HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients 32
Totale 14.989
Categoria #
all - tutte 42.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.060 24 56 26 58 160 120 40 66 37 47 117 309
2022/20231.535 194 239 119 172 124 170 12 102 276 17 93 17
2023/20241.128 92 94 133 72 134 191 57 38 35 74 80 128
2024/20253.291 42 108 66 189 219 336 397 169 303 415 410 637
2025/20264.140 247 467 532 356 433 376 609 201 256 483 122 58
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 14.989